Microneedle Drug Delivery Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa

Microneedle Drug Delivery Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)


The global healthcare industry is witnessing a transformative shift in drug delivery methods, particularly in the field of transdermal drug administration. The conventional approach of hypodermic needles for injections has long been associated with various risks such as needle injuries, pain perception, and limitations of skin transport barriers. In this context, microneedle arrays (MNA) have emerged as an ideal solution for minimally invasive and painless drug delivery through the skin, bypassing the stratum corneum and disrupting the traditional drug delivery landscape.

Microneedles Minimize Patient Trypanophobia, Paving the Way for Immunisation Programs

Microneedle drug delivery offers several advantages, including faster onset, improved efficacy, and higher patient compliance. By providing therapeutic benefits and delivering reproducible results with pinpoint accuracy and minimal variability in bioavailability, microneedles are revolutionizing drug delivery methods. One of the significant advantages of microneedles is their ability to minimize patient trypanophobia, which is the fear of needles. This aspect is increasing adoption rates in the paediatrics segment and bolstering mass immunisation programs. With higher efficiency in drug delivery control compared to other transdermal methods, microneedles are shaping the future of drug administration.

Microneedle Companies Collaborate with Vaccine Manufacturers to Ensure Success

Leading players in the microneedle drug delivery market, such as NanoPass Technologies, are collaborating with immunotherapy companies to leverage their proprietary MicronJet technology in the development of affordable, effective, and safe COVID-19 vaccines. Other prominent companies in the market include 3M, Microdermics, Zosano Pharma Corporation (ZSAN), Nitto Denko Corporation, Becton, Dickinson and Company, Vaxxas Pty Ltd, Valeritas (Zealand Pharma A/S), Corium, Inc., TheraJect, Inc., LTS Lohmann Therapie-Systeme AG, and Alza Corporation. The shared intellectual property between these companies and vaccine manufacturers is expected to play a pivotal role in ensuring successful drug delivery.

Versatility of Microneedle Arrays Enables Innovative Drug Delivery Solutions

The demand for therapies where active substances are not effectively absorbed through oral administration has driven the innovation of newer nanoparticle and microparticle drug encapsulation technologies. Transdermal administration, especially with ovalbumin as the most common protein antigen for immunisation studies using microneedle arrays, has shown immense promise. Microneedles have also garnered significant interest in the cosmetics and diagnostics industries, with clinical trials being conducted for wearable epidermal diagnostic devices. The unique attributes of microneedle arrays allow them to open up limitless opportunities for rectal, oral, ocular, and buccal drug delivery.

Low Manufacturing Cost Fuels Popularity of Hollow Microneedle Arrays

The microneedle drug delivery market offers various fabrication options, including dissolving, hollow, hydrogel, and solid microneedle arrays. While solid microneedles made from silicon or metal are well-established and have a longer product lifespan, polymer microneedle arrays have witnessed significant growth in recent years. Hollow microneedle arrays are particularly favored due to their precise drug control, low cost, and ease of manufacturing. These attributes contribute to their popularity and widespread use in the microneedle drug delivery market.

As the global healthcare industry continues to emphasize innovation and patient-centric drug delivery methods, microneedle arrays are set to play a pivotal role in revolutionizing transdermal drug administration.

Please Note: It will take 5 business days to complete the report upon order confirmation.

Please note: The PDF e-mail from publisher version of this report is for a global site license.


1. Executive Summary
1.1. Global Microneedle Drug Delivery Market Outlook, 2018 - 2030 (US$ Million)
1.2. Global Microneedle Drug Delivery Market Incremental Opportunity, 2018 - 2030 (US$ Million)
1.3. Key Industry Trends
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.1.1. Driver 1
2.2.1.2. Driver 2
2.2.2. Restraints
2.2.2.1. Restraint 1
2.2.2.2. Restraint 2
2.2.3. Opportunities
2.2.3.1. Opportunity 1
2.2.3.2. Opportunity 2
2.3. Regulatory Scenario
2.4. Technological Advancements
2.5. Microneedle Array Research Publications Trend Analysis (2000-2019)
2.6. Clinical Trials Analysis
2.7. Marketed microneedle-based transdermal products
2.8. List of patents by :
2.8.1. Microneedle array technologies
2.8.2. Fabrication of mold
2.8.3. Therapeutic drugs delivered
2.9. COVID-19 Impact Analysis
3. Global Microneedle Drug Delivery Outlook, 2018 - 2030
3.1. Global Microneedle Drug Delivery Market Outlook, By Product, 2018 - 2030
3.1.1. Key Highlights
3.1.2. Global Microneedle Drug Delivery Market Outlook, by Product, Value (US$ Million), 2018 - 2030
3.1.2.1. Coated Microneedles
3.1.2.2. Dissolving Microneedles
3.1.2.3. Hollow Microneedles
3.1.2.4. Hydrogel Microneedles
3.1.2.5. Solid Microneedles
3.1.3. Global Microneedle Drug Delivery Market Share and BPS Analysis, by Product, 2023 and 2030
3.1.4. Global Microneedle Drug Delivery Market Attractiveness Analysis, by Product, 2023 - 2030
3.2. Global Microneedle Drug Delivery Market Outlook, By Application, 2018 - 2030
3.2.1. Key Highlights
3.2.2. Global Microneedle Drug Delivery Market Outlook, by Application, Value (US$ Million), 2018 - 2030
3.2.2.1. Bio-macromolecule Delivery
3.2.2.2. Combination Therapy
3.2.2.3. Diagnostics
3.2.2.4. Drug Delivery
3.2.2.5. Ocular Drug Delivery
3.2.2.6. Vaccine & Gene Delivery
3.2.3. Global Microneedle Drug Delivery Market Share and BPS Analysis, by Application, 2023 and 2030
3.2.4. Global Microneedle Drug Delivery Market Attractiveness Analysis, by Application, 2023 - 2030
3.3. Global Microneedle Drug Delivery Market Outlook, By Region, 2018 - 2030
3.3.1. Key Highlights
3.3.2. Global Microneedle Drug Delivery Market Outlook, by Region, Value (US$ Million), 2018 - 2030
3.3.2.1. North America
3.3.2.2. Europe
3.3.2.3. Asia Pacific
3.3.2.4. Latin America
3.3.2.5. Middle East & Africa
3.3.3. Global Microneedle Drug Delivery Market Share and BPS Analysis, by Region, 2023 and 2030
3.3.4. Global Microneedle Drug Delivery Market Attractiveness Analysis, by Region, 2023 - 2030
4. North America Microneedle Drug Delivery Market Outlook, 2018 - 2030
4.1. North America Microneedle Drug Delivery Market Outlook, By Product, 2018 - 2030
4.1.1. Key Highlights
4.1.2. North America Microneedle Drug Delivery Market Outlook, by Product, Value (US$ Million), 2018 - 2030
4.1.2.1. Coated Microneedles
4.1.2.2. Dissolving Microneedles
4.1.2.3. Hollow Microneedles
4.1.2.4. Hydrogel Microneedles
4.1.2.5. Solid Microneedles
4.1.3. North America Microneedle Drug Delivery Market Share and BPS Analysis, by Product, 2023 and 2030
4.2. North America Microneedle Drug Delivery Market Outlook, By Application, 2018 - 2030
4.2.1. Key Highlights
4.2.2. North America Microneedle Drug Delivery Market Outlook, by Application, Value (US$ Million), 2018 - 2030
4.2.2.1. Bio-macromolecule Delivery
4.2.2.2. Combination Therapy
4.2.2.3. Diagnostics
4.2.2.4. Drug Delivery
4.2.2.5. Ocular Drug Delivery
4.2.2.6. Vaccine & Gene Delivery
4.2.3. North America Microneedle Drug Delivery Market Share and BPS Analysis, by Application, 2023 and 2030
4.3. North America Microneedle Drug Delivery Market Outlook, By Country, 2018 - 2030
4.3.1. Key Highlights
4.3.2. North America Microneedle Drug Delivery Market Outlook, by Country, Value (US$ Million), 2018 - 2030
4.3.2.1. U.S.
4.3.2.2. Canada
4.3.3. North America Microneedle Drug Delivery Market Share and BPS Analysis, by Country, 2023 and 2030
5. Europe Microneedle Drug Delivery Market Outlook, 2018 - 2030
5.1. Europe Microneedle Drug Delivery Market Outlook, By Product, 2018 - 2030
5.1.1. Key Highlights
5.1.2. Europe Microneedle Drug Delivery Market Outlook, by Product, Value (US$ Million), 2018 - 2030
5.1.2.1. Coated Microneedles
5.1.2.2. Dissolving Microneedles
5.1.2.3. Hollow Microneedles
5.1.2.4. Hydrogel Microneedles
5.1.2.5. Solid Microneedles
5.1.3. Europe Microneedle Drug Delivery Market Share and BPS Analysis, by Product, 2023 and 2030
5.2. Europe Microneedle Drug Delivery Market Outlook, By Application, 2018 - 2030
5.2.1. Key Highlights
5.2.2. Europe Microneedle Drug Delivery Market Outlook, by Application, Value (US$ Million), 2018 - 2030
5.2.2.1. Bio-macromolecule Delivery
5.2.2.2. Combination Therapy
5.2.2.3. Diagnostics
5.2.2.4. Drug Delivery
5.2.2.5. Ocular Drug Delivery
5.2.2.6. Vaccine & Gene Delivery
5.2.3. Europe Microneedle Drug Delivery Market Share and BPS Analysis, by Application, 2023 and 2030
5.3. Europe Microneedle Drug Delivery Market Outlook, By Country, 2018 - 2030
5.3.1. Key Highlights
5.3.2. Europe Microneedle Drug Delivery Market Outlook, by Country, Value (US$ Million), 2018 - 2030
5.3.2.1. Germany
5.3.2.2. France
5.3.2.3. U.K.
5.3.2.4. Italy
5.3.2.5. Spain
5.3.2.6. Russia
5.3.2.7. Rest of Europe
5.3.3. Europe Microneedle Drug Delivery Market Share and BPS Analysis, by Country, 2023 and 2030
6. Asia Pacific Microneedle Drug Delivery Market Outlook, 2018 - 2030
6.1. Asia Pacific Microneedle Drug Delivery Market Outlook, By Product, 2018 - 2030
6.1.1. Key Highlights
6.1.2. Asia Pacific Microneedle Drug Delivery Market Outlook, by Product, Value (US$ Million), 2018 - 2030
6.1.2.1. Coated Microneedles
6.1.2.2. Dissolving Microneedles
6.1.2.3. Hollow Microneedles
6.1.2.4. Hydrogel Microneedles
6.1.2.5. Solid Microneedles
6.1.3. Asia Pacific Microneedle Drug Delivery Market Share and BPS Analysis, by Product, 2023 and 2030
6.2. Asia Pacific Microneedle Drug Delivery Market Outlook, By Application, 2018 - 2030
6.2.1. Key Highlights
6.2.2. Asia Pacific Microneedle Drug Delivery Market Outlook, by Application, Value (US$ Million), 2018 - 2030
6.2.2.1. Bio-macromolecule Delivery
6.2.2.2. Combination Therapy
6.2.2.3. Diagnostics
6.2.2.4. Drug Delivery
6.2.2.5. Ocular Drug Delivery
6.2.2.6. Vaccine & Gene Delivery
6.2.3. Asia Pacific Microneedle Drug Delivery Market Share and BPS Analysis, by Application, 2023 and 2030
6.3. Asia Pacific Microneedle Drug Delivery Market Outlook, By Country, 2018 - 2030
6.3.1. Key Highlights
6.3.2. Asia Pacific Microneedle Drug Delivery Market Outlook, by Country, Value (US$ Million), 2018 - 2030
6.3.2.1. Japan
6.3.2.2. China
6.3.2.3. India
6.3.2.4. Australia & New Zealand
6.3.2.5. South Korea
6.3.2.6. Rest of Asia Pacific
6.3.3. Asia Pacific Microneedle Drug Delivery Market Share and BPS Analysis, by Country, 2023 and 2030
7. Latin America Microneedle Drug Delivery Market Outlook, 2018 - 2030
7.1. Latin America Microneedle Drug Delivery Market Outlook, By Product, 2018 - 2030
7.1.1. Key Highlights
7.1.2. Latin America Microneedle Drug Delivery Market Outlook, by Product, Value (US$ Million), 2018 - 2030
7.1.2.1. Coated Microneedles
7.1.2.2. Dissolving Microneedles
7.1.2.3. Hollow Microneedles
7.1.2.4. Hydrogel Microneedles
7.1.2.5. Solid Microneedles
7.1.3. Latin America Microneedle Drug Delivery Market Share and BPS Analysis, by Product, 2023 and 2030
7.2. Latin America Microneedle Drug Delivery Market Outlook, By Application, 2018 - 2030
7.2.1. Key Highlights
7.2.2. Latin America Microneedle Drug Delivery Market Outlook, by Application, Value (US$ Million), 2018 - 2030
7.2.2.1. Bio-macromolecule Delivery
7.2.2.2. Combination Therapy
7.2.2.3. Diagnostics
7.2.2.4. Drug Delivery
7.2.2.5. Ocular Drug Delivery
7.2.2.6. Vaccine & Gene Delivery
7.2.3. Latin America Microneedle Drug Delivery Market Share and BPS Analysis, by Application, 2023 and 2030
7.3. Latin America Microneedle Drug Delivery Market Outlook, By Country, 2018 - 2030
7.3.1. Key Highlights
7.3.2. Latin America Microneedle Drug Delivery Market Outlook, by Country, Value (US$ Million), 2018 - 2030
7.3.2.1. Brazil
7.3.2.2. Mexico
7.3.2.3. Argentina
7.3.2.4. Rest of Latin America
7.3.3. Latin America Microneedle Drug Delivery Market Share and BPS Analysis, by Country, 2023 and 2030
8. Middle East & Africa Microneedle Drug Delivery Market Outlook, 2018 - 2030
8.1. Middle East & Africa Microneedle Drug Delivery Market Outlook, By Product, 2018 - 2030
8.1.1. Key Highlights
8.1.2. Middle East & Africa Microneedle Drug Delivery Market Outlook, by Product, Value (US$ Million), 2018 - 2030
8.1.2.1. Coated Microneedles
8.1.2.2. Dissolving Microneedles
8.1.2.3. Hollow Microneedles
8.1.2.4. Hydrogel Microneedles
8.1.2.5. Solid Microneedles
8.1.3. Middle East & Africa Microneedle Drug Delivery Market Share and BPS Analysis, by Product, 2023 and 2030
8.2. Middle East & Africa Microneedle Drug Delivery Market Outlook, By Application, 2018 - 2030
8.2.1. Key Highlights
8.2.2. Middle East & Africa Microneedle Drug Delivery Market Outlook, by Application, Value (US$ Million), 2018 - 2030
8.2.2.1. Bio-macromolecule Delivery
8.2.2.2. Combination Therapy
8.2.2.3. Diagnostics
8.2.2.4. Drug Delivery
8.2.2.5. Ocular Drug Delivery
8.2.2.6. Vaccine & Gene Delivery
8.2.3. Middle East & Africa Microneedle Drug Delivery Market Share and BPS Analysis, by Application, 2023 and 2030
8.3. Middle East & Africa Microneedle Drug Delivery Market Outlook, By Country, 2018 - 2030
8.3.1. Key Highlights
8.3.2. Middle East & Africa Microneedle Drug Delivery Market Outlook, by Country, Value (US$ Million), 2018 - 2030
8.3.2.1. Saudi Arabia
8.3.2.2. UAE
8.3.2.3. Israel
8.3.2.4. South Africa
8.3.2.5. Rest of Middle East & Africa
8.3.3. Middle East & Africa Microneedle Drug Delivery Market Share and BPS Analysis, by Country, 2023 and 2030
9. Competitive Landscape
9.1. Market Share Analysis, 2022
9.2. Company Profiles
9.2.1. 3M Corp.
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product Pipeline
9.2.1.4. Recent Developments
9.2.2. Becton, Dickinson and Company
9.2.3. Corium International Inc.
9.2.4. CosMED Pharmaceutical Co. Ltd.
9.2.5. Debiotech
9.2.6. Derma spark
9.2.7. NanoPass Inc.
9.2.8. Sanofi Pasteur
9.2.9. TheraJect Inc.
9.2.10. Valeritas Inc.
9.2.11. Zosano Pharma Inc.
10. Appendix
10.2. Research Methodology
10.3. Report Specific Research Approach
10.4. Acronyms and Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings